Navigation Links
Medbox, Inc. Initiates "Responsible Consumption" Campaign for Marijuana in Recreational States
Date:2/4/2013

HOLLYWOOD, Calif., Feb. 4, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), announced that they have initiated a program through their public education division that will engage in an informational campaign featuring printed literature to be distributed to future retail marijuana establishments as well as online support services through a website. The theme of the informational literature and website will be a "responsible consumption" campaign that Medbox believes is a necessary educational component in the post-prohibition marijuana era in the states of Colorado and Washington. As mentioned in a prior press release, the entity will also offer free expertise to newly adopted recreational marijuana states on how to create systems, procedures, and regulations that provide the utmost in legal compliance, accountability and transparency.

"Now that some states have chosen to view marijuana as they would alcohol, the correct plan of action needs to evolve around understanding the plant and educating the public about the positive and negative effects while under the influence of the drug," stated Vincent Mehdizadeh , Founder and Senior Consultant at Medbox, Inc. "Whether you are for or against the recreational use of marijuana, the reality is that the voters in two states have spoken and systems to control and tax the drug, like the products Medbox offers, are more relevant than ever before. Similarly, educating the public should be a focus for companies like Medbox that are taking a leadership role in the maturation period of this burgeoning industry."

In other news, the company announced that they have signed term sheets with two noteworthy and very relevant bio-tech companies in vertical industries parallel to Medbox. The deals have evolved into draft definitive agreement status
'/>"/>

SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Snoasis Medical Initiates Distribution in Japan Through Hausten Healthcare
2. Applied Genetics Initiates Commercial Operation
3. Research Alert -- Empire Asset Management Co. Initiates Coverage on Exact Sciences (NASDAQ: EXAS)
4. Baxter Initiates Phase I Clinical Trial of Longer-acting Recombinant FVIII Treatment for Hemophilia A
5. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
6. Adult Stem Cell Therapy Breakthrough Leads to Crowd Funding Campaign on Indiegogo.com for Centagen, Inc.
7. New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated Californias Prop 37
8. Mandy Moore Campaigns for Clean Water, GreenBeanBuddy Encourages Mothers to Help Through the Use of Green Cleaning Products
9. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
10. UV Flu Technologies to Commence a National TV Advertising Campaign
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... 2014 Omnia Education , the ... today announced the launch of a nationwide educational series ... Breast pain is the most common breast symptom for ... women report mild breast pain while evidence shows more ... lifespan. Along with breast pain and tenderness, FBC may ...
(Date:11/15/2014)... , Nov. 14, 2014 Algenol Biofuels will present ... the Oceanographic Museum of Monaco . ... Monaco is an annual invitation-only event hosted by Innovator Capital, ... Other partners and sponsors include Prince Albert ... & Burling, Cranfield University, PR Newswire, the Monte-Carlo SBM, Oceanographic ...
(Date:11/15/2014)... -- F. David Rollo , MD, Ph.D., FACC, FACNP ... Professional in the field of Medicine as a result ... Cell Point is a privately held biotechnology ... , Houston and ... ethylenedicysteine drug conjugate technology ("EC Technology"), In-Situ Hydrogel ("In ...
(Date:11/12/2014)... SEATTLE , Nov. 12, 2014  ReachBio Research ... Seattle, WA ) announced today that it ... Tokyo, Japan ), giving Funakoshi non-exclusive distribution ... the life science research market within Japan ... promote ReachBio,s specialized contract research services to Japanese drug ...
Breaking Biology Technology:Omnia Education Launches Nationwide Educational Series on Breast Pain and Fibrocystic Breast Changes Affecting Half of all Women 2Omnia Education Launches Nationwide Educational Series on Breast Pain and Fibrocystic Breast Changes Affecting Half of all Women 3Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2F. David Rollo, MD, Ph.D., FACC, FACNP is recognized by Continental Who's Who as a Pinnacle Professional 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3
... Vasogen to also Raise $7.5 Million in Non-Dilutive ... MISSISSAUGA, ON, Aug. 17 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: ... have entered into a definitive agreement, subject to shareholder and ... plan of arrangement and merger to continue as a publicly-traded ...
... , , SAN DIEGO, Aug. ... Chair Professor of the Department of Biochemistry and Director of ... and Technology (HKUST), has joined their scientific advisory board. ... recipient of China,s highest honor in the natural sciences, the ...
... , , ... Inc. (OTC Bulletin Board: BLFS), a leading manufacturer and marketer ... that it has entered into a non-exclusive distribution agreement with ... a member of the StemCell Group of companies, is a ...
Cached Biology Technology:Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 2Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 3Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 4Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 5Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 6Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 7Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 8Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company 9Professor Nancy Ip Joins aTyr Pharma's Scientific Advisory Board 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 2BioLife Solutions and STEMCELL Technologies Announce Worldwide Distribution Agreement 3
(Date:11/7/2014)... by Dr. Debra Auguste, associate professor, biomedical engineering, ... City College of New York, have identified a ... one of the most aggressive forms of breast ... a high mortality rate owing to aggressive proliferation ... options. However, Professor Auguste,s team, discovered the overexpression ...
(Date:11/6/2014)... is an asset for a predator. Except when that predator ... tiger beetle, relative to its size, is the fastest creature ... body lengths per second (at about five miles per hour). ... take the sprinting gold from the tiger beetle, a person ... The tiger beetle has a problem. At peak speeds, everything ...
(Date:11/4/2014)... – University of Utah engineers developed the first room-temperature ... produce electricity without needing to ignite the fuel. These ... electronics, off-grid power and sensors. , A study of ... Chemical Society journal ACS Catalysis . , Fuel ... between a fuel and an oxygen-rich source such as ...
Breaking Biology News(10 mins):The tiger beetle: Too fast to see 2Jet-fueled electricity at room temperature 2
... New Orleans, LA LSU Health Sciences Center New ... years by the National Center for Research Resources (NCRR), ... This Center of Biological Research Excellence (COBRE) grant funds ... enabling them to successfully compete nationally for research funding. ...
... more soot for the amount of fuel used than other ... as much soot as previously estimated, according to the first ... and the University of Colorado conducted the study and present ... Geophysical Research Letters . The primary sources ...
... in the current issue of the journal , Environmental ... in sea spray, attacks and damages DNA in the ... body,s way of ,disposing the toxin inadvertently converts it ... brevetoxins produced by the red tide ,organism, Karenia ...
Cached Biology News:LSUHSC awarded $10M+ COBRE grant 2LSUHSC awarded $10M+ COBRE grant 3LSUHSC awarded $10M+ COBRE grant 4NOAA takes first broad look at soot from ships 2Aerosol toxins from red tides may cause long-term health threat 2
Mouse monoclonal antibody raised against a partial recombinant NEK2. NCBI Entrez Gene ID = NEK2...
... Major Science Smart Minis 300V power ... with ever higher voltage, sufficient for SDS-PAGE, ... specifications ensure two pairs of terminator pairs ... Supply is designed for individuals to have ...
... is a premium quality recombinant form of ... is suitable for a wide range of ... and reproducible performance, each preparation is extensively ... assays. NovaTaq DNA Polymerase possesses an integral ...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Biology Products: